4//SEC Filing
Alexza Pharmaceuticals Inc. 4
Accession 0001209191-16-129191
CIK 0001344413operating
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 3:12 PM ET
Size
6.9 KB
Accession
0001209191-16-129191
Insider Transaction Report
Form 4
Grupo Ferrer Internacional, S.A.
10% Owner
Transactions
- Purchase
Common Stock
2016-06-21$0.90/sh+19,465,714$17,519,143→ 21,832,649 total(indirect: See Footnotes)
Ferrer-Salat Sergio
10% Owner
Transactions
- Purchase
Common Stock
2016-06-21$0.90/sh+19,465,714$17,519,143→ 21,832,649 total(indirect: See Footnotes)
Footnotes (3)
- [F1]Purchase price paid consisted of $0.90 cash and a contingent value right.
- [F2]Ownership is held indirectly through a wholly owned subsidiary.
- [F3]Mr. Ferrer-Salat, as the Chairman and controlling shareholder of Grupo Ferrer Internacional S.A. ("Grupo Ferrer") may be deemed a beneficial owner of the securities held by Grupo Ferrer, but disclaims ownership thereof except to the extent of his pecuniary interest therein.
Documents
Issuer
Alexza Pharmaceuticals Inc.
CIK 0001344413
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001344413
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 3:12 PM ET
- Size
- 6.9 KB